Factors affecting prognosis of patients with intracranial anaplastic oligodendrogliomas: a single institutional review of 70 patients

被引:18
作者
Yang, Liu-song [1 ]
Huang, Feng-ping [1 ]
Zheng, Kang [1 ]
Zhang, Hai-shi [1 ]
Zhou, Xiang [1 ]
Bao, Xu-hui [1 ]
Zheng, Jia-jun [1 ]
Chang, Chuan [1 ]
Zhou, Liang-fu [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China
关键词
Anaplastic oligodendroglioma; Intracranial tumor; Prognosis; Survival; GRADE-III; DIAGNOSIS; SURVIVAL; OLIGOASTROCYTOMAS; ASTROCYTOMAS; CHEMOTHERAPY; MANAGEMENT; FEATURES; GLIOMAS; 1P;
D O I
10.1007/s11060-010-0146-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Anaplastic oligodendroglioma (AO) is an uncommon intracranial tumor and prognosis is poor. In this study, we assessed the factors affecting the prognosis of AO patients. Seventy AO patients were recruited from 2001 to 2006 in Shanghai Huashan Hospital of Fudan University; all were treated surgically. Kaplan-Meier survival analysis and Cox regression analysis were used to analyze the prognostic effects of 14 different factors, which were selected from clinical, radiological, pathological, and treatment variables. The results showed that chemotherapy, age, primary or secondary tumors, preoperative Karnofsky Performance Scale (KPS) scores, the presence of epilepsy at initial presentation, radiological contrast infusion, and neurological parameters all correlated with the prognosis of the patients. Furthermore, Cox multivariate analysis also showed that the age (P < 0.048), primary or secondary tumors (P < 0.010), and chemotherapy (P < 0.010) were significantly correlated with the prognosis of the patients. Age and chemotherapy correlated with the prognosis of AO. The patients younger than 50 years old and who received regular chemotherapy were likely to achieve a good outcome. Moreover, individualized treatment after molecular biological typing of AO may improve the prognosis of AO.
引用
收藏
页码:113 / 120
页数:8
相关论文
共 22 条
[11]   Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III [J].
Kristof, RA ;
Neuloh, G ;
Hans, V ;
Deckert, M ;
Urbach, H ;
Schlegel, U ;
Simon, M ;
Schramm, J .
JOURNAL OF NEURO-ONCOLOGY, 2002, 59 (03) :231-237
[12]   OLIGODENDROGLIOMA - THE ROTTERDAM-DIJKZIGT EXPERIENCE [J].
KROS, JM ;
PIETERMAN, H ;
VANEDEN, CG ;
AVEZAAT, CJJ .
NEUROSURGERY, 1994, 34 (06) :959-966
[13]   Panel review of anaplastic oligodendroglioma from European Organization for Research and Treatment of Cancer Trial 26951: Assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome [J].
Kros, Johan M. ;
Gorlia, Thierry ;
Kouwenhoven, Mathilde C. ;
Zheng, Ping-Pin ;
Collins, V. Peter ;
Figarella-Branger, Dominique ;
Giangaspero, Felice ;
Giannini, Caterina ;
Mokhtari, Karima ;
Mork, Sverre J. ;
Paetau, Anders ;
Reifenberger, Guido ;
van den Bent, Martin J. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (06) :545-551
[14]   Long-term outcome of oligodendrogliomas [J].
Lebrun, C ;
Fontaine, D ;
Ramaioli, A ;
Vandenbos, F ;
Chanalet, S ;
Lonjon, M ;
Michiels, JF ;
Bourg, V ;
Paquis, P ;
Chatel, M ;
Frenay, M .
NEUROLOGY, 2004, 62 (10) :1783-1787
[15]   Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p [J].
Mukasa, A ;
Ueki, K ;
Matsumoto, S ;
Tsutsumi, S ;
Nishikawa, R ;
Fujimaki, T ;
Asai, A ;
Kirino, T ;
Aburatani, H .
ONCOGENE, 2002, 21 (25) :3961-3968
[16]   Postoperative radiotherapy and chemotherapy in the management of oligodendroglioma: single institutional review of 88 patients [J].
Ozyigit, G ;
Onal, C ;
Gurkaynak, M ;
Soylemezoglu, F ;
Zorlu, F .
JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (02) :189-193
[17]   Anaplastic oligodendrogliomas: Prognostic factors for tumor recurrence and survival [J].
Puduvalli, VK ;
Hashmi, M ;
McAllister, LD ;
Levin, VA ;
Hess, KR ;
Prados, M ;
Jaeckle, KA ;
Yung, WKA ;
Buys, SS ;
Bruner, JM ;
Townsend, JJ ;
Davis, R ;
Sawaya, R ;
Kyritsis, AP .
ONCOLOGY, 2003, 65 (03) :259-266
[18]   Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology [J].
Reifenberger, G ;
Louis, DN .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (02) :111-126
[19]  
SIMON RP, 2000, NEUROLOGICAL EXAMINA, P344
[20]   Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas [J].
Smith, JS ;
Perry, A ;
Borell, TJ ;
Lee, HK ;
O'Fallon, J ;
Hosek, SM ;
Kimmel, D ;
Yates, A ;
Burger, PC ;
Scheithauer, BW ;
Jenkins, RB .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) :636-645